[
  {
    "patent_id": "US872556A1",
    "title": "hi pain management novel formulation and delivery mechanism",
    "assignee": "Johnson & Johnson",
    "inventors": [
      "Sara Kim",
      "Emily Zhang"
    ],
    "filing_year": 2017,
    "publication_year": 2017,
    "expiry_year": 2037,
    "therapeutic_area": "Pain management",
    "abstract": "This invention relates to an improved pharmaceutical formulation of hi, designed for enhanced pain management. The composition includes modified excipients which result in improved bioavailability, reduced first-pass metabolism, and superior therapeutic control. The formulation offers manufacturing advantages and potential clinical benefit compared to existing products.",
    "status": "Pending",
    "pdf_link": "https://patents.google.com",
    "url": "https://patents.google.com"
  },
  {
    "patent_id": "US857424A1",
    "title": "hi liver safety formulations novel formulation and delivery mechanism",
    "assignee": "Generic Pharma Co.",
    "inventors": [
      "Sara Kim",
      "Emily Zhang"
    ],
    "filing_year": 2016,
    "publication_year": 2018,
    "expiry_year": 2038,
    "therapeutic_area": "Liver safety formulations",
    "abstract": "This invention relates to an improved pharmaceutical formulation of hi, designed for enhanced liver safety formulations. The composition includes modified excipients which result in improved bioavailability, reduced first-pass metabolism, and superior therapeutic control. The formulation offers manufacturing advantages and potential clinical benefit compared to existing products.",
    "status": "Active",
    "pdf_link": "https://patents.google.com",
    "url": "https://patents.google.com"
  },
  {
    "patent_id": "US758662A1",
    "title": "hi extended-release technology novel formulation and delivery mechanism",
    "assignee": "Pfizer Inc.",
    "inventors": [
      "Amit Sharma",
      "Emily Zhang"
    ],
    "filing_year": 2017,
    "publication_year": 2018,
    "expiry_year": 2039,
    "therapeutic_area": "Extended-release technology",
    "abstract": "This invention relates to an improved pharmaceutical formulation of hi, designed for enhanced extended-release technology. The composition includes modified excipients which result in improved bioavailability, reduced first-pass metabolism, and superior therapeutic control. The formulation offers manufacturing advantages and potential clinical benefit compared to existing products.",
    "status": "Expired",
    "pdf_link": "https://patents.google.com",
    "url": "https://patents.google.com"
  },
  {
    "patent_id": "US191998A1",
    "title": "hi fever reduction novel formulation and delivery mechanism",
    "assignee": "Generic Pharma Co.",
    "inventors": [
      "John Doe",
      "Carlos Gomez"
    ],
    "filing_year": 2019,
    "publication_year": 2020,
    "expiry_year": 2031,
    "therapeutic_area": "Fever reduction",
    "abstract": "This invention relates to an improved pharmaceutical formulation of hi, designed for enhanced fever reduction. The composition includes modified excipients which result in improved bioavailability, reduced first-pass metabolism, and superior therapeutic control. The formulation offers manufacturing advantages and potential clinical benefit compared to existing products.",
    "status": "Expired",
    "pdf_link": "https://patents.google.com",
    "url": "https://patents.google.com"
  },
  {
    "patent_id": "US628378A1",
    "title": "hi liver safety formulations novel formulation and delivery mechanism",
    "assignee": "Sun Pharma",
    "inventors": [
      "Priya Nair",
      "Carlos Gomez"
    ],
    "filing_year": 2020,
    "publication_year": 2018,
    "expiry_year": 2030,
    "therapeutic_area": "Liver safety formulations",
    "abstract": "This invention relates to an improved pharmaceutical formulation of hi, designed for enhanced liver safety formulations. The composition includes modified excipients which result in improved bioavailability, reduced first-pass metabolism, and superior therapeutic control. The formulation offers manufacturing advantages and potential clinical benefit compared to existing products.",
    "status": "Active",
    "pdf_link": "https://patents.google.com",
    "url": "https://patents.google.com"
  },
  {
    "patent_id": "US716703A1",
    "title": "hi inflammation novel formulation and delivery mechanism",
    "assignee": "Sun Pharma",
    "inventors": [
      "Priya Nair",
      "Carlos Gomez"
    ],
    "filing_year": 2021,
    "publication_year": 2023,
    "expiry_year": 2030,
    "therapeutic_area": "Inflammation",
    "abstract": "This invention relates to an improved pharmaceutical formulation of hi, designed for enhanced inflammation. The composition includes modified excipients which result in improved bioavailability, reduced first-pass metabolism, and superior therapeutic control. The formulation offers manufacturing advantages and potential clinical benefit compared to existing products.",
    "status": "Pending",
    "pdf_link": "https://patents.google.com",
    "url": "https://patents.google.com"
  }
]